Previous close | 16.47 |
Open | N/A |
Bid | 12.00 |
Ask | 19.30 |
Strike | 580.00 |
Expiry date | 2025-06-20 |
Day's range | 16.47 - 16.47 |
Contract range | N/A |
Volume | |
Open interest | 3 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning